Thermo Fisher expands biobank, bioanalysis

Thermo Fisher Scientific is adding capacity across three adjacent parts of the biopharma supply chain at once: clinical bioanalysis, biobanking and commercial manufacturing. On May 19, the company highlighted a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, and announced a strategic collaboration with Precision Health Research, Singapore, or PRECISE, on the PRECISE-SG100K study. (businesswire.com) Separately, Thermo Fisher has completed technology transfer and product-introduction work tied to Nuvation Bio’s oncology drug Ibtrozi. Taken together, the moves show Thermo Fisher extending its role from research support into sample storage, proteomics and late-stage manufacturing support. (news-medical.net) The company described the Gothenburg site as part of its PPD clinical research business, while the Singapore collaboration sits within its biobank and proteomics offering through Olink, now part of Thermo Fisher. Yahoo Finance reported the Ibtrozi work as another manufacturing milestone in oncology. ### Why does the Gothenburg lab matter now? Gothenburg became a focus for Thermo Fisher’s laboratory expansion in Europe when the company said its PPD clinical research business added a new bioanalytical lab at GoCo Health Innovation City. The site is intended to serve pharmaceutical and biotech customers across all phases of drug development with bioanalytical and biomarker testing services. (businesswire.com) The PPD unit said the Sweden expansion adds advanced laboratory services and instrumentation for clinical development programs. That places Thermo Fisher deeper inside outsourced trial workflows, where sponsors often rely on external partners for sample analysis and biomarker work. ### What is PRECISE-SG100K, and what is Thermo Fisher doing there? PRECISE-SG100K is a Singapore population-scale biobank initiative that Thermo Fisher described as one of the region’s most ambitious and diverse. (businesswire.com) In its May 19 announcement, the company said the collaboration with PRECISE will support proteomics work for the study, which is designed to advance population health and precision-medicine research. Olink, the proteomics business now owned by Thermo Fisher, is the named platform behind that effort. (businesswire.com) The announcement said the collaboration is aimed at advancing large-scale protein analysis tied to the Singapore cohort, extending Thermo Fisher’s reach beyond instruments and into long-duration biobank infrastructure and data generation. ### Where does Ibtrozi fit into this picture? Nuvation Bio said it completed a technology-transfer partnership with Thermo Fisher for manufacturing Ibtrozi, according to a Yahoo Finance report published May 19. A separate Yahoo Finance item published days earlier said Nuvation selected Thermo Fisher for final drug-product manufacturing of Ibtrozi in the United States. Ibtrozi adds an oncology manufacturing reference for Thermo Fisher’s pharma services business. (news-medical.net) The reported work moves beyond research support and into commercial supply responsibilities, linking Thermo Fisher to production steps closer to launch and patient delivery. That reading is an inference from the reported technology-transfer and final-manufacturing roles. ### How do these pieces connect? Three separate announcements point to the same operating pattern: Thermo Fisher is building presence around workflows that begin with samples, move through biomarker and proteomic analysis, and can extend into manufacturing support. (news-medical.net) The Gothenburg lab covers clinical bioanalysis, the PRECISE-SG100K collaboration covers biobanking and proteomics, and the Ibtrozi work adds commercial manufacturing execution. For buyers and partners near those workflows, the practical effect is that Thermo Fisher is becoming involved in more stages of the same program. (finance.yahoo.com) The company’s next visible milestones are the execution of PRECISE-SG100K proteomics work in Singapore and planned U.S. final drug-product manufacturing for Ibtrozi with Nuvation Bio. (news-medical.net) (businesswire.com) (finance.yahoo.com)